Home/Pipeline/Panaxia Sublingual Tablet

Panaxia Sublingual Tablet

Chronic Pain, Spasticity

CommercialActive

Key Facts

Indication

Chronic Pain, Spasticity

Phase

Commercial

Status

Active

Company

About Panaxia

Israeli pharma‑grade cannabis developer delivering standardized oral and inhalation products for global markets.

View full company profile

Therapeutic Areas

Pain Management Neurology Oncology Supportive Care